Evidence map›Paper›PMID 39609715›Full record

ArticleJournal of cheminformatics2024

cidalsDB: an AI-empowered platform for anti-pathogen therapeutics research.

Emna Harigua-Souiai, Ons Masmoudi, Samer Makni, Rafeh Oualha, Yosser Z Abdelkrim, Sara Hamdi, Oussama Souiai, Ikram Guizani

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emna Harigua-SouiaiLaboratory of Molecular Epidemiology and Experimental Pathology - LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia. emna.harigua@pasteur.utm.tn.
Ons MasmoudiLaboratory of Molecular Epidemiology and Experimental Pathology - LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia.
Samer MakniLaboratory of Molecular Epidemiology and Experimental Pathology - LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia.
Rafeh OualhaLaboratory of Molecular Epidemiology and Experimental Pathology - LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia.
Yosser Z AbdelkrimLaboratory of Molecular Epidemiology and Experimental Pathology - LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia.
Sara HamdiLaboratory of Molecular Epidemiology and Experimental Pathology - LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia.
Oussama SouiaiLaboratory of BioInformatics, BioMathematics and BioStatistics - LR20IPT09, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia.
Ikram GuizaniLaboratory of Molecular Epidemiology and Experimental Pathology - LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, 13, Place Pasteur, 1002, Tunis, Tunisia.

Funding

European Commission DCI-PANAF/2020/420-028Ministry of Higher Education and Research of the Republic of Tunisia LR16IPT04United States Agency for International Development AID-OAA-A-11-00012
6 · The paper itself

Abstract

Computer-aided drug discovery (CADD) is nurtured by late advances in big data analytics and Artificial Intelligence (AI) towards enhanced drug discovery (DD) outcomes. In this context, reliable datasets are of utmost importance. We herein present CidalsDB a novel web server for AI-assisted DD against infectious pathogens, namely Leishmania parasites and Coronaviruses. We performed a literature search on molecules with validated anti-pathogen effects. Then, we consolidated these data with bioassays from PubChem. Finally, we constructed a database to store these datasets and make them accessible and ready-to-use for the scientific community through CidalsDB, a web-based interface. In a second step, we implemented and optimized four machine learning (ML) and three deep learning (DL) algorithms that optimally predicted the biological activity of molecules. Random Forests (RF), Multi-Layer Perceptron (MLP) and ChemBERTa were the best classifiers of anti-Leishmania molecules, while Gradient Boosting (GB), Graph-Convolutional Network (GCN) and ChemBERTa achieved the best performances on the Coronaviruses dataset. All six models were optimized and deployed through CidalsDB as anti-pathogen activity prediction models.Scientific contributionCidalsDB is an open access web-based tool that allows browsing and access to ready-to-use datasets of anti-pathogen molecules, alongside best performing AI models for biological activity prediction. It offers a democratized no-code platform for AI-based CADD, which shall foster innovation and collaboration within the DD community. CidalsDB is accessible through https://cidalsdb.streamlit.app/ .

Indexed as

DatabaseDeep learningDrug discoveryMachine learning

Identifiers

PMID39609715
PMCPMC11605991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.